Abstract
Central venous catheter related blood stream infections (CRBSI) increase morbidity and mortality in pediatric hematopoietic stem cell transplant (HSCT) recipients. There are limited data in the pediatric HSCT population regarding the incidence of CRBSI. Studies in adult oncology and HSCT patients have reported the average rate to be 2.5 CRBSI per 1000 patient-days. We hypothesized that adherence to evidence-based practices shown to reduce CRBSI in short term central venous lines (CVLs) would also reduce CRBSI in long term CVLs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
